CNS small molecules
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
394
NCT05105243
Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 17, 2022
Completion: Nov 21, 2022
NCT06553027
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Phase: Phase 3
Start: Sep 20, 2024
Completion: Mar 31, 2026
Loading map...